| Text | duration | start | ents | sentiment | 
|---|---|---|---|---|
| the second anti-viral drug along with | 4.08 | Jump to 7.2 | 
 | |
| 19. so now we have vaccines we have | 5.04 | Jump to 13.12 | 
 | |
| 30 | 3.439 | Jump to 95.04 | 
 | |
| and death if given in that first three | 3.841 | Jump to 98.479 | 
 
 | |
| to five days of onset of symptoms | 4.32 | Jump to 100.479 | 
 | |
| whereas pfizer is close to almost 90 | 4.4 | Jump to 102.32 | 
 | |
| only approved for 18 and up and not for | 5.28 | Jump to 113.439 | 
 | |
| whereas pfizer is approved for age 12 | 4.639 | Jump to 126.96 | 
 | |
| 88 pounds but there are some uh | 4.561 | Jump to 131.599 | 
 | |
| take six pills a day almost three | 5.84 | Jump to 136.16 | 
 | |
| morning and night for five days and uh | 5.599 | Jump to 138.72 | 
 
 | |
| best prepare yourself to battle covet 19 | 4.881 | Jump to 200.239 | 
 | |
| is still number one prevention is key | 4.961 | Jump to 207.519 | 
 | |
| even mild and moderate cases of covet 19 | 4.88 | Jump to 212.48 | 
 | |
| two years later we don't know how long | 4.401 | Jump to 218.959 | 
 | |
| effect profiles of these two antivirals | 3.92 | Jump to 223.36 | 
 | |
| hopefully by the winter of 2022 we're | 4.159 | Jump to 264.32 | 
 |